Integrating genomic features for non-invasive early lung cancer detection JJ Chabon, EG Hamilton, DM Kurtz, MS Esfahani, EJ Moding, H Stehr, ... Nature 580 (7802), 245-251, 2020 | 519 | 2020 |
Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA DM Kurtz, J Soo, L Co Ting Keh, S Alig, JJ Chabon, BJ Sworder, A Schultz, ... Nature biotechnology 39 (12), 1537-1547, 2021 | 210 | 2021 |
Phased variant enrichment for enhanced minimal residual disease detection from cell-free DNA DM Kurtz, J Soo, S Alig, LCT Keh, C Macaulay, MC Jin, F Scherer, ... Blood 134, 552, 2019 | 7 | 2019 |
Phased variants improve DLBCL minimal residual disease detection at the end of therapy. DM Kurtz, JJ Chabon, J Soo, L Co Ting Keh, S Alig, A Schultz, MC Jin, ... Journal of Clinical Oncology 39 (15_suppl), 7565-7565, 2021 | 4 | 2021 |
Leveraging phased variants for personalized minimal residual disease detection in localized non-small cell lung cancer. DM Kurtz, JJ Chabon, B Sworder, L Co Ting Keh, J Soo, S Alig, A Schultz, ... Journal of Clinical Oncology 39 (15_suppl), 8518-8518, 2021 | 3 | 2021 |